BackTable Urology

Are you interested in designing and managing clinical trials in the year ahead? In this episode of the BackTable Urology Podcast, Dr. Behfar Ehdaie, a urologist at Memorial Sloan Kettering Cancer Center, joins host Aditya Bagrodia. Their discussion centers around novel methods and practical implementation strategies for clinical trials in urology. Dr. Ehdaie shares personal experiences from starting pilot trials, engaging stakeholders, and integrating trial processes into clinical practice. He also discusses mechanisms to reduce cost and improve enrollment while explaining the concept of two-stage consent to minimize patient anxiety. This episode aims to provide valuable pearls for young investigators and experienced practitioners alike on conducting successful clinical trials. Listen here: https://lnkd.in/gSdd5PAB Thank you to Photocure for supporting this episode! Learn more at https://www.photocure.com/ #Uro207 #residency #BackTable #Urology #Urologist

Thank you for listening to BackTable Urology. We value your feedback. Please take 30 seconds to help us improve the podcast! Those who submit the survey will receive a promo code for 20% off BackTable Merch! https://lnkd.in/gjpbueuW

Have you checked out the AUA/ASTRO/SUO’s recently released guidelines for salvage therapy in prostate cancer biochemical recurrence? In this episode of the BackTable Urology Podcast, guest Dr. Todd Morgan from the University of Michigan and host Aditya Bagrodia continue part two of a discussion in prostate cancer biochemical recurrence management. They focus on the difficulty in declaring a patient 'cured' and the implications of biochemical recurrence after treatment. Dr. Morgan highlights the importance of PSA in the postoperative setting and explores the role of the Decipher Prostate Genomic Classifier in personalizing treatment. He shares insights on the latest AUA/ASTRO/SUO consensus on biochemical recurrence guidelines, including the significance of early salvage therapy and the integration of advanced imaging techniques like PSMA PET scans. Further, he emphasizes the role for multidisciplinary evaluation, patient counseling, and future directions of research to refine treatment options. The discussion underscores the transition from adjuvant to early salvage radiation as a standard practice and considers emerging biomarker strategies to inform treatment decisions. Listen here: https://lnkd.in/eJQYuwyU Thank you to Veracyte for supporting this episode! Learn more at https://www.veracyte.com/ #Uro206 #residency #BackTable #Urology #Urologist

Dr. Tim Masterson and Dr. Rob Hamilton discuss strategies for managing complex surgical cases involving vascular control and preoperative planning. Check out the full episode here: https://lnkd.in/eucxFPEB #URO202 #urologysurgery #urology #medicaleducation

Dr. Tim Masterson and Dr. Rob Hamilton discuss the importance of balancing confidence and patient safety in surgery, emphasizing dedication to individual patients and openness to consulting colleagues for optimal outcomes. Check out the full epiosde: https://ow.ly/6hjM50UnSt9 #URO201 #urologysurgery #urology #medicaleducation

Dr. Tim Masterson shares his decision making process in choosing incision types and his considerations in surgical procedures, particularly for testicular and retroperitoneal tumors. Check out the full episode here: https://ow.ly/jCOO50UnSh9 #URO201 #urology #urologysurgery #medicaleducation

In this episode of the BackTable Urology Podcast, host Dr. Jose Silva welcomes Dr. C Shawn West to discuss the contemporary management of Benign Prostatic Hyperplasia (BPH). Dr. West, who practices at McIver Clinic in Florida, shares his detailed approach to optimizing patient experiences with BPH. He delves into initial patient consultation, diagnostic procedures, and diverse treatment options including UroLift, GreenLight laser therapy, and Aquablation. Dr. West emphasizes the importance of individualized patient care, the role of objective symptom scoring systems, and the significance of setting realistic expectations for patients. The discussion also covers the benefits and challenges of different BPH treatments amidst the evolving landscape of minimally invasive urological procedures. Listen here: https://lnkd.in/gW5NKkxA Thank you to Teleflex for supporting this episode! Learn more at https://lnkd.in/g_9K7GS2 #Uro205 #residency #BackTable #Urology #Urologist

Can you believe it's almost the end of 2024? It's #SpotifyWrapped2024 season! Here are our most streamed episodes of the year: Check them out if you haven't already! Which episodes/guests would you like to hear about in 2025? James Eastham Edward Schaeffer, MD, PhD Abraham Morgentaler MD Aditya Bagrodia Dr. Jose E Silva Ruchika Talwar Yash Shah Quynh-Chi (Chi) Dang

Stay up to date in your bladder cancer practice with this insightful episode of the BackTable Urology podcast, developed in collaboration with the Society of Urologic Oncology. Dr. Betsy Koehne (University of Wisconsin) and Dr. Amir Salmasi (UC San Diego) talk through the contemporary management of low and intermediate-risk non-muscle-invasive bladder cancer. The doctors explore the challenges and nuances of patient communication, intravesical therapy, and postoperative surveillance. They also cover emerging treatments and clinical trials that hold promise for improving patient outcomes and quality of life. Emphasis is placed on the distress experienced by patients and the need for personalized treatments. Listen here: https://lnkd.in/g_9AtQds #Uro204 #residency #BackTable #Urology #Urologist

Interested in the implications of the latest research in low risk prostate cancer for treating your patients? In this episode of the BackTable Urology Podcast, host Dr. Aditya Bagrodia welcomes Dr. Dan Lin, urologist at the University of Washington, to explore prostate cancer diagnosis, surveillance, and management. Their discussion covers the latest advancements in prostate cancer research, focusing on Grade Group 2 disease. They delve into real-world implementation of active surveillance, alongside the use of advanced diagnostics, biopsy methods, and personalized care plans. The conversation highlights the Canary Prostate Active Surveillance Study (PASS) and the prognostic role of biomarkers and genomic testing. They also discuss how lifestyle factors such as diet impact cancer progression and how patients can be empowered to manage their disease. Additionally, strategies for transitioning patients off surveillance are highlighted. Finally, the two experts discuss insights from recent clinical trials like PIVOT, PROTECT, and SPCG and evolving standards in prostate cancer management. Listen here:  https://lnkd.in/gxCc3AjM #Uro203 #residency #BackTable #Urology #Urologist Thank you to Veracyte for supporting this episode! Learn more at https://www.veracyte.com/